2024 DIA Singapore Annual Meeting

OVERVIEW

The rapid evolution of drug development and technology, coupled with regulatory advances have created new opportunities and challenges in healthcare. It is critical for regulators, academia, patients, and industries to collaborate closely to ensure an evolving and robust regulatory ecosystem that enables accelerated and cost-effective access to innovative healthcare solutions. This year, DIA Singapore Annual Meeting aims to bring regulators, patient representatives and industries to share and discuss ways in cultivating synergies in clinical research and the regulatory environment to innovate healthcare in APAC. Come join us and be a part of the discussions to explore the challenges and actions that stakeholders in APAC can adopt to ensure transformations in the healthcare evolution.

FEATURED TOPICS

• Future regulatory ecosystem
• Accelerating and Streamlining Accelerating Procedures
• Drug Development and Innovation in Clinical Research
• New Regulatory Fields and Trends
• The influence of emerging regulatory strategies and trends on the surveillance of medicines after they have been approved
• Clinical Research Regulations